The CRO sector has experienced a sharp uptick in the short term, with Chengda Pharmaceutical at the forefront, witnessing a surge of over 10% in its share price. Other notable players, including SunTech Medical, Medison, Sino Biopharmaceutical, Sichuan Shuangma, and Dezhan Health, have also recorded increases in their share prices.
